Roche in Medical News
Navigation Links
Roche in Medical News
Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems, Inc.
PORTON DOWN, England, July 16 /PRNewswire/ -- Enigma Diagnostics Limited, the decentralized and point-of-care molecular diagnostics company, announced today that it has signed two patent license agreements with Roche Molecular Systems, Inc. (RMS). The licenses signed on 15 July 2009,...Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier
Roche to fund evaluation of Raptor's proprietary NeuroTrans(TM) technology NOVATO, Calif., June 9 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced that it has entered a collaboration and licensing agreement with Roc...moksha8 Expands Alliance With Roche to Commercialize $200 Million of Products in Brazil and Mexico
MEXICO CITY, SAO PAULO and PHILADELPHIA, May 20 /PRNewswire/ -- moksha8, Inc. announced today that it has expanded its strategic partnership with Roche to commercialize an additional portfolio of products in Mexico currently generating sales of $140 million USD. moksha8 will commercialize pr...Corporate Pandemic Preparedness Experts from Roche & PSEG to Advise Savvy Business Leaders May 15
CHAPEL HILL, N.C., May 7 /PRNewswire/ -- When the unpredictable influenza season returns in the fall, health care officials warn that the seemingly lessening threat of the H1N1 outbreak may worsen. Operating under pandemic contingency plans already, nearly one-third of companies do not have a po...Gen-Probe, Roche Prevail in Arbitration With Digene Concerning Human Papillomavirus Agreement
SAN DIEGO, April 1 /PRNewswire-FirstCall/ -- Gen-Probe (Nasdaq: GPRO ) announced today that the Company, along with its co-respondents F. Hoffmann-La Roche Ltd. and Roche Molecular Systems, Inc., has prevailed in its arbitration with Digene (now Qiagen) concerning the Company's supply and purcha...Beauty Care Sales and Marketing Veteran to Drive International Retail Expansion, With Near Term Focus on Top Selling AcneFree Product Group and New WrinkleFree Brand Line Extension IRVINE, Calif., Jan. 21 /PRNewswire/ -- University Medical Pharmaceuticals, a leading developer and distributo...
Recent Entrants Invest Heavily in Promotion to Capture Share in Mature Market, According to a New Report from Decision Resources WALTHAM, Mass., Jan. 14 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues,...
Fujirebio Diagnostics and Roche Diagnostics Sign Agreement for New Ovarian Cancer Test
Fujirebio Diagnostics' HE4 Test will be Available Through Roche Diagnostics' Automated Immunoassay Analyzers MALVERN, Pa. and Basel, SwitzerlandDec. 16 /PRNewswire/ -- Fujirebio Diagnostics, Inc. and Roche Diagnostics announced today a worldwide license and supply agreement for the HE4 ov...PORTON DOWN, England and SAN FRANCISCO, Dec. 16 /PRNewswire/ -- Enigma Diagnostics Limited, the decentralized and point-of-care molecular diagnostics company, announced today that it has signed a term sheet for two patent license agreements with Roche Molecular Systems, Inc. (RMS). The li...
New Roche Dual Target HIV-1 Test Approved for Use in European Union
PLEASANTON, Calif., Dec. 15 /PRNewswire/ -- Roche announced today that its innovative dual-target HIV-1 test has received CE Mark certification, allowing it to be sold for clinical use in the European Union. The COBAS(R) AmpliPrep/COBAS(R) TaqMan(R) HIV-1 Test, v2.0 utilizes a unique design to si...Three Florida residents took Accutane as teens, developed inflammatory bowel disease; Plaintiffs represented jointly by law firms Hook Bolton; Seeger Weiss; and Beggs & Lane ATLANTIC CITY, N.J., Nov. 20 /PRNewswire/ -- In another major courtroom verdict linking powerful acne medicati...
VANCOUVER, June 26 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) announced today that it has entered into an agreement granting rights to Roche Diagnostics to market its line of cardiovascular point-of-care (POC) tests worldwide. Roche Diagnostics' comprehen...
New Roche Chlamydia Test Approved for Use in European Union
Test offers more reliable detection of Chlamydia trachomatis, the most commonly reported sexually transmitted disease in Europe. PLEASANTON, Calif., June 13 /PRNewswire/ -- Roche announced today that its new test for detection of Chlamydia trachomatis has received CE Mark certification,...Press Statement: Roche Affirms That Tamiflu(R) is in Ample Supply Nationwide
NUTLEY, N.J., Feb. 19 /PRNewswire/ -- In response to recent media reports, Roche would like to reaffirm that there is ample supply of Tamiflu(R) (oseltamivir phosphate) antiviral medication for the 2007-2008 flu season, and that physicians and patients can feel confident the drug is on hand if...Baylor College of Medicine increases fleet of Roche Genome Sequencer FLX Systems to 10 instruments
INDIANAPOLISThe Human Genome Sequencing Center at Baylor College of Medicine boosted its sequencing capabilities with an agreement to acquire seven additional Genome Sequencer FLX Systems from 454 Life Sciences, a Roche company. With 10 Genome Sequencer FLX Systems, the Human Genome Sequencing...Nation's Largest Healthcare Alliance Adds Roche HIV-1 Test to Existing Contract
Premier offers new Roche assay as its only real-time PCR test for HIV INDIANAPOLIS, Oct. 12 /PRNewswire/ -- Premier Inc., the nation's largest healthcare alliance, gave its 1,700 hospital members access in August to the Roche COBAS(R) Ampliprep/COBAS(R) TaqMan(R) HIV-1 assay -- the only real-...FDA Approves New Roche West Nile Virus Blood Screening Test
Automated test helps ensure safety of blood supply by detecting virus earlier in infection cycle. PLEASANTON, Calif., Aug. 28 /PRNewswire/ -- Roche Diagnostics announced that the US Food & Drug Administration (FDA) today approved its biologics license application for the ...Improved Testing for Hepatitis B Virus From Roche
PLEASANTON, Calif., Dec. 8 /PRNewswire/ -- Roche Molecular Diagnostics announced today that it has received CE Mark certification for its new COBAS(R) AmpliPrep / COBAS(R) TaqMan(R) HBV Test v2.0, allowing it to be sold for clinical use in the European Union. This highly sensitive test offers Roc...New Lung Cancer Drug Launched By Roche Pharmaceutical
Major Pharmaceutical Company Roche launched its anti-cancer drug `Tarceva' (erlotinib), which `prolongs and improves' quality of life of patients//, suffering from lung cancer. The Managing Director Dr G L Telang said, it was an oral tablet taken once a day and has the potential to treat many ...PDL BioPharma Elects Barry Selick to Its Board of Directors
...on of fully humanized antibody therapeutics and applied this technology to PDL's first product, Zenapax (R), which was developed and commercialized by roche for the prevention of kidney transplant rejection. Dr. Selick received his B.S. and Ph.D. from the University of Pennsylvania and was a Damon Runyon-W...Gen-Probe Reports Financial Results for Second Quarter 2009
... 4,100 Cash paid for investment in DiagnoCure and related license fees (5,250) - Cash paid for roche manufacturing access fees - (10,000) Other assets (...Roche Cardiac 200 Offers Rapid Cardiac Diagnostics for the Point of Care
... INDIANAPOLIS, July 22 /PRNewswire/ -- roche Diagnostics announced today the introduction of the roche Cardiac 200, a comprehensive testing solution for ... The latest addition to an expanding portfolio of roche Diagnostics cardiac solutions, the...Moores UCSD Cancer Center Luau and Longboard Invitational Hosts Survivor Beach Aug. 9
...factures and commercializes medicines to treat patients with serious or life-threatening medical conditions. The company, a wholly-owned member of the roche Group, has headquarters in South San Francisco, California and a manufacturing and clinical operations facility in Oceanside, California. For additi...New Report Just Published: World Multiple Myeloma Therapeutics Market Report
...quibb Company, Kosan Biosciences, Inc., Celgene Corporation, F. Hoffmann-La roche Ltd, Genentech, Inc., Genta Incorporated, Millennium Pharmaceuticals, Ortho...es, Inc. (USA) II-55 Celgene Corporation (USA) II-56 F. Hoffmann-La roche Ltd (Switzerland) II-56 Genentech, Inc. (USA) II-56 Genta Incorpora...New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report
...GmbH, Bristol-Myers Squibb Company, F. Hoffmann-La roche Ltd., GlaxoSmithKline plc, Hayashibara Biochemical...ond (includes corresponding Graph/Chart) II-13 roche & Schering - Dominant Players in HCV Therapeutics Market II-14 HCV Drugs from roche & Schering II-14 Partnerships in R&D B......roduct candidates will not be repeated or observed in ongoing or future studies involving our product candidates, the risk that our collaboration with roche will not continue or will not be successful and the risk that any one or more of our product candidates will not be successfully developed and commerc...
..." said Sr. Vice President & General Manager of roche Diabetes Care North America Luc Vierstraete. "The...matter. "A worldwide strategic objective for roche is to 'Enable Diabetes Management,'" Vierstraete s...we feel certain this can be achieved." About roche Diabetes Care ...
...arma AG, Biogen Idec Inc., Bristol-Myers Squibb Company, Chugai Pharmaceutical Co., Ltd., Elan Corporation, plc, Eli Lilly And Company, F. Hoffmann-La roche AG, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Inc., Merck Serono SA, Novartis AG, sanofi-aventis SA, Schering-Plough Corporation, S...
...ncreased Use of Existing Agents from Eli Lilly and roche Will Drive Growth, According to a New Report from ...stin and OSI/Roche/Chugai's Tarceva, Eli Lilly and roche dominated the NSCLC landscape in 2008 as each comp...ncreased uptake of Avastin and Tarceva will enable roche to retain 29 percent of overall market share. Addi...
... roche and Schering-Plough Will Continue to be Prominent Players in the Market, Ac...specific agents and an increase in the size of the drug-treated population. roche and Schering-Plough will continue to be prominent players and a number of o...
...(Thermo Fisher Scientific) Promega Quantum Dot (Life Technologies (Invitrogen)) R&D Systems (division of TECHNE Corp., Nasdaq: TECH ) roche Applied Science Rockland Immunochemicals SABiosciences Santa Cruz Biotechnology Serotec (MorphoSys) Sigma-Aldrich (Nasdaq: SIAL ) Ups...
...itazar - NUTLEY, N.J., June 9 /PRNewswire/ -- roche today announced it will start Phase III clinical i...s likely to more than double by 2030. About roche Hoffmann-La roche Inc. (Roche), based in Nutley, N.J., is the U.S. p...
...roduct candidates will not be repeated or observed in ongoing or future studies involving our product candidates, the risk that our collaboration with roche will not continue or will not be successful and the risk that any one or more of our product candidates will not be successfully developed and commerc...
New Diabetes Drug Shows Promise in Trial
...n," wrote a team led by Dr. Robert R. Henry of the University of California, San Diego. The study was funded by aleglitazar's maker, F. Hoffmann-La roche AG. More information Today's oral medications for diabetes are described by the American Diabetes Association . ...NEJM study points to new era in hepatitis C treatment
...cNair and John Alam of Vertex Pharmaceuticals. Drs. Jacobson, McHutchison and Muir have received consulting fees and/or grant support from Vertex, roche (maker of peginterferon) and Schering-Plough (maker of ribavirin). The study's results match those of a similar study conducted in Europe that was...Sean Hurley Joins Ameritox as Vice President for Insurance and Managed Care Contracting
...ed in progressively senior positions at leading organizations in the pharmaceutical, biotech and laboratory industries including Quest Diagnostics and roche Laboratories. During his tenure with Novo Nordisk (2001-2008), Hurley's success in sales growth and work with payors prompted three promotions in......hritis - NUTLEY, N.J., June 4 /PRNewswire/ -- roche today announced that oral and poster presentations...xtensive clinical development program conducted by roche includes five Phase III clinical studies and has e...EMRA is part of a co-development agreement between roche and Chugai Pharmaceutical Co. In June 2005, ACTEMR...
...), OSI Pharmaceuticals, Inc. (Nasdaq: OSIP ) and roche today announced the initiation of a Phase 3 trial ...lease visit http://www.osip.com . About roche Headquartered in Basel, Switzerland, roche is a leader in research-focused healthcare with co...
Response Biomedical Closes $12.65 million Unit Offering
...ntage for capital acquisitions related to manufacturing capacity expansion to meet product demand created by the Company's corporate partnerships with roche Diagnostics, 3M Health Care and Shionogi & Co., Ltd. About Response Biomedical Response Biomedical develops, manufactures and markets ra...Pharmasset to Present at Deutsche Bank Healthcare Conference
...roduct candidates will not be repeated or observed in ongoing or future studies involving our product candidates, the risk that our collaboration with roche will not continue or will not be successful and the risk that any one or more of our product candidates will not be successfully developed and commerc...Other TagsOther Contentstransfectiontransfectiontransfectiontransienttransienttransienttransienttransienttransienttranslocationtranslocationtranslocationtranslocationtranslocationtranslocationproteinsproteinsproteinsproteinsproteinsproteinsproteinsproteinsproteinselementelementelementelementelementelementelementelementelementtransposabletransposabletransposasetranspositiontransposition
CrayfishCucumberWhitefishCodfishCloveGarbanzoChickpeaChestnutCheddarCeleryMusselPaprikaBassBlackAvocado
(Date:11/25/2009)...isch, Head of the Cell Death Research Laboratory i... has been awarded the prestigious Johnson & Johnso... the cause of brain cell damage in Parkinson,s dis...entists in support of innovation and excellence in...nferred earlier this month at an event at the Hyat...
(Date:11/24/2009)...f years it has been prescribed by traditional heal...adaches and stomach pain to fever and flu. , Now ...rsity have been able to scientifically prove the p...rwise known as Brazilian mint. , Testing this anc...researcher Graciela Rocha was able to show that wh...
(Date:11/24/2009)...l action of a remarkable class of ring-shaped prot...the Lawrence Berkeley National Laboratory (Berkele...raphy beamline at the Advanced Light Source (ALS)....xpression and replication, and are vital to the su...ous agents, such as the human papillomavirus, whic...
Breaking Biology News(10 mins):Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Got a pain? -- Have a cup of Brazilian mint 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Healthcare 3A Public Option Mirrors Other Government Insurance Plans 55035 1Healthcare 3A Public Option Mirrors Other Government Insurance Plans 55035 2Robots gentle touch aids delicate cancer surgery 55030 1Robots gentle touch aids delicate cancer surgery 55030 2Robots gentle touch aids delicate cancer surgery 55030 3Seeing the tree from the forest 3A Predicting the future of plant communities 9656 1Seeing the tree from the forest 3A Predicting the future of plant communities 9656 2(Date:11/27/2009)...ll/--TheGymboreeCorporation(Nasdaq: GYMB )announce...X23rdInvestorProgram,whichwillbeheldattheMayFairHo...1:45a.m.GMT. ,, TolistentoalivebroadcastofTheGy...aselogontowww.gymboree.com,clickon"OurCompany"atth...dthen"ConferenceCalls&Webcasts."Thewebcastwill...
(Date:11/27/2009)... may reduce future disease burden, researchers say... Encouraging city dwellers to walk and bicycle ins... health benefits than increased used of low-emissi... study compared the projected health effects in 20...or London, England, and Delhi, India: business-as...
(Date:11/27/2009)...rers who use medical load cells at the heart of th...nging in technology partner Flintec early in the d...dical manufacturers are calling in Flintec load ce... ensuring that progress will not be constrained by... technology. , (PRWEB) No...
(Date:11/26/2009)...ate (TM) has been shown in studies to be effective...sed by an overload of copper, and certain metastat...er, is known about how the drug works at the molec...iversity researchers now has provided an invaluabl...d to copper-loaded metallochaperones. The drug seq...
(Date:11/26/2009)...ntal (RTDental), a leading dental group practice i...nsion of its services to include LUMINEERS by a ce..., Durham, NC (PRWEB) -- Re... Dr. Doug Macmillan, an experienced LUMINEERS De...raining seminar. RTDental’s ability to fulf...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2[0] The Gymboree Corporation to Present at NASDAQ OMX 23rd Investor Program[0] More Foot Power, Less Car Pollution Best for Health[0] Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells[1] Research sheds light on workings of anti-cancer drug[0] Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |